Safety in an Evolving Psychedelic Landscape: Knowledge and Use of Psilocybin Safety Strategies, Resources, and Support in a Naturalistic Oregon Sample

Background Real-world psilocybin use outpaces evidence-based guidance and accessible professional support; understanding psilocybin safety strategy and resource utilization is important for informing education and dissemination initiatives. Methods This qualitative study explored the perspectives of Oregon residents ( N = 31) who plan to/have used psilocybin, employing thematic analysis of one-on-one interviews to examine how individuals find, evaluate, and utilize information, safety strategies, and support services. Data collection occurred July–August, 2024. Results Within Theme 1 ( Foundations for Safer/Beneficial Use ) participants shared several foundational safety strategies, such as attending to source/dose, and mindset and setting, though exhibited several knowledge gaps, such as of substance testing kits. Theme 2 ( Education/Accessing Information ) found that participants primarily obtained information online and through personal networks, and desired consistent, trustworthy information. Theme 3 ( Use of Supports/Services ) indicated that several participants relied on peer support or trip sitters; few were aware of community supports or state-regulated services. Participants viewed unregulated guides as more accessible, with trustworthiness, reputation, and rapport prioritized over formal credentials. Theme 4 ( Interfacing with Healthcare Providers ) revealed participants often desired provider support, but encountered barriers (lack of provider knowledge, legal concerns, fear of stigma). Conclusions This is the first qualitative evidence on psilocybin safety strategies within the era of Oregon’s state-regulated access. Results revealed several novel insights, including potentially low state-regulated service awareness, emphasis on both communal and individual safety and barriers to open communication with healthcare providers. Improved resource dissemination (testing kits, trustworthy educational sources) and healthcare provider training around psilocybin are needed.